The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest interventional oncology devices market share.

The global interventional oncology devices market is expected to grow from $2.21 billion in 2022 to $2.35 billion in 2023 at a compound annual growth rate (CAGR) of 6.4%. The interventional oncology devices market size is expected to grow from $3.03 billion in 2027 at a CAGR of 6.5%.

Major Driver In The Interventional Oncology Devices Market ­– Rise In The Product Recalls
For example, the Boston Scientific Corporation’s IceFORCE 2.1 CX Prostate Cryoablation Kit Visual ICE System was recalled in June 2020 because the needle surface had degraded. Medtronic recalled the Pipeline Flex embolisation system with Shield technology in March 2020 due to a fracture in the distal part. These product recalls put financial hardship on firms while also reducing demand, hampered the market.

View More On The Interventional Oncology Devices Market Report 2023 – https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Key Interventional Oncology Devices Market Segments
1) By Product: Embolization Devices, Ablation Devices, Support Devices
2) By Procedure: Thermal Tumor Ablation, Non-thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE) or Bland Embolization
3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types

Recent Interventional Oncology Devices Market Trend – Deploying Robotics Technology
For more efficiency, companies are concentrating on deploying robotics technology in interventional oncology equipment. With greater accuracy and efficiency, the robotic system merges image-based planning and navigation with the placement of various instruments to the required body component. For example, the US Food and Drug Administration authorised Quantum Surgical’s Epione interventional oncology robotics platform in March 2022.

Interventional Oncology Devices Market Prominent Players
Major players in the interventional oncology devices market are Boston Scientific Corporation, Medtronic PLC., Terumo Corporation, Merit Medical Systems Inc., Philips Volcano, AngioDynamics Inc., GE Healthcare, Siemens Healthineers, Sirtex Medical, and Cook Medical Incorporated.

Request A Sample Of The Global Interventional Oncology Devices Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp

The Interventional Oncology Devices Global Market Report 2023  provides a comprehensive overview on the interventional oncology devices market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the interventional oncology devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Interventional oncology devices employ minimally invasive procedures and modern imaging technology to diagnose and treat cancer.

View More Related Reports –
Interventional Neurology Devices And Equipment Global Market Report 2023
Oncology Biosimilars Global Market Report 2023
Oncology Devices Global Market Report 2023

Contact us at
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model